Cargando…
Case Report: A Case of Valproic Acid-Induced Hyperammonemic Encephalopathy Associated With the Initiation of Lithium: A Re-duplicable Finding
INTRODUCTION: Hyperammonemic encephalopathy (HAE) is a serious adverse effect of valproate semisodium, which is facilitated by the potential for drug interaction. However, despite frequent co-prescription of valproate semisodium and lithium, the role of this combination in the occurrence of HAE has...
Autores principales: | Levy, Anna, Very, Etienne, Montastruc, François, Birmes, Philippe, Jullien, Adeline, Richaud, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108155/ https://www.ncbi.nlm.nih.gov/pubmed/35586415 http://dx.doi.org/10.3389/fpsyt.2022.875636 |
Ejemplares similares
-
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017) -
Valproic acid-induced hyperammonemic encephalopathy: a clinical case
por: Felizardo, M., et al.
Publicado: (2022) -
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014)